Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01058681
Other study ID # Swiss national science fund
Secondary ID Grant number 320
Status Completed
Phase N/A
First received January 28, 2010
Last updated August 2, 2011
Start date January 2010
Est. completion date October 2010

Study information

Verified date October 2010
Source Centre Hospitalier Universitaire Vaudois
Contact n/a
Is FDA regulated No
Health authority Switzerland: Federal Office of Public Health
Study type Interventional

Clinical Trial Summary

This study will evaluate the potential effects of a changing metabolic environment on GnRH hypothalamic neurons, by performing studies of LH pulsatility (basal and during clamp studies) in different groups of male subjects fed isocaloric and hypercaloric diets. The participation of other gastro-intestinal tract hormones to these regulations will be systematically evaluated.


Recruitment information / eligibility

Status Completed
Enrollment 9
Est. completion date October 2010
Est. primary completion date October 2010
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 25 Years
Eligibility Inclusion Criteria:

- male

- age between 18 and 25 years old

- no known pathology

- normal physical exam

- BMI between 20 and 25 kg/m2

Exclusion Criteria:

- history of endocrine disease

- no known infertility (no conception after 12 months of regular unprotected intercourse)

- abnormal results on the initial blood tests (CBC, fasting glucose and insulin, HbA1C, TSH, free T4, LH, FSH, inhibin B and total testosterone)

Study Design

Allocation: Non-Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Basic Science


Related Conditions & MeSH terms

  • Neuroendocrine Reproductive Status

Intervention

Dietary Supplement:
effect of metabolic variations on LH pulsatility
Isocaloric diet: 1,5 times basal metabolism. Constitution:55% carbohydrates, 15% proteins and 30% fat. Hypercaloric diet: addition of 30% fat and 3 g of fructose/kg of weight to isocaloric diet. PO and IV glucose during clamps: PO administration of 90 mg/kg glucose at 90 minutes intervals during the clamp, and adjustment of the IV perfusion to keep euglycemia.

Locations

Country Name City State
Switzerland CHUVaudois Lausanne

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire Vaudois

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Luteinizing hormone (LH) pulsatility 2 years No